{"id":162354,"date":"2022-05-23T01:48:18","date_gmt":"2022-05-23T05:48:18","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/kala-announces-entry-into-definitive-agreement-to-sell-eysuvis-and-inveltys-to-alcon-inc\/"},"modified":"2024-08-18T11:44:32","modified_gmt":"2024-08-18T15:44:32","slug":"kala-announces-entry-into-definitive-agreement-to-sell-eysuvis-and-inveltys-to-alcon-inc","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/kala-announces-entry-into-definitive-agreement-to-sell-eysuvis-and-inveltys-to-alcon-inc.php","title":{"rendered":"Kala Announces Entry into Definitive Agreement to Sell EYSUVIS\u00ae and INVELTYS\u00ae to Alcon Inc."},"content":{"rendered":"<p><![CDATA[--Kala Will Receive $60 Million in Upfront Payment; Eligible to Receive Additional Sales-Based Milestone Payments----Kala Will Focus Resources on Phase 2\/3 Trial of KPI-012 for Orphan Disease Persistent Corneal Epithelial Defect--ARLINGTON, Mass., May  23, 2022  (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that it has entered into a definitive agreement to sell its commercial portfolio and related intellectual property assets to Alcon Inc. This includes EYSUVIS, the first and only U.S. Food and Drug Administration (FDA) approved medicine for the short-term (up to two weeks) treatment of the signs and symptoms of dry eye disease, and INVELTYS, a twice-a-day corticosteroid for the treatment of post-operative inflammation and pain following ocular surgery.]]><\/p>\n<p>Go here to read the rest:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2022\/05\/23\/2448029\/0\/en\/Kala-Announces-Entry-into-Definitive-Agreement-to-Sell-EYSUVIS-and-INVELTYS-to-Alcon-Inc.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Kala Announces Entry into Definitive Agreement to Sell EYSUVIS\u00ae and INVELTYS\u00ae to Alcon Inc.\">Kala Announces Entry into Definitive Agreement to Sell EYSUVIS\u00ae and INVELTYS\u00ae to Alcon Inc.<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Go here to read the rest: Kala Announces Entry into Definitive Agreement to Sell EYSUVIS\u00ae and INVELTYS\u00ae to Alcon Inc. <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/kala-announces-entry-into-definitive-agreement-to-sell-eysuvis-and-inveltys-to-alcon-inc.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-162354","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/162354"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=162354"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/162354\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=162354"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=162354"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=162354"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}